trial

Brain Stimulation, Clinical Symptoms and Cognition

NCTId NCT05053451
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 5 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2024-04-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
5 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2021-09-14
Primary completion
2024-04-10
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
transcranial direct current stimulation

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Sites

1 total
Sacramento, United States

Facts & assertions

4 sourced
Enrollment
5
Phase
NA
Primary Completion Date
2024-04-10
Status
COMPLETED
relationships
The graph out of here
drug
transcranial direct current stimulation
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizophrenia
indication
Hallucinations
indication
Schizophrenia
indication